TCR: A Transformer Based Deep Network for Predicting Cancer Drugs Response

• URL: http://arxiv.org/abs/2207.04457v1
• Date: Sun, 10 Jul 2022 13:01:54 GMT
• Title: TCR: A Transformer Based Deep Network for Predicting Cancer Drugs Response
• Authors: Jie Gao, Jing Hu, Wanqing Sun, Yili Shen, Xiaonan Zhang, Xiaomin Fang, Fan Wang, and Guodong Zhao
• Abstract summary: We proposeTransformer based network for Cancer drug Response (TCR) to predict anti-cancer drug response. By utilizing an attention mechanism, TCR is able to learn the interactions between drug atom/sub-structure and molecular signatures efficiently. Our study highlights the prediction power of TCR and its potential value for cancer drug repurpose and precision oncology treatment.
• Score: 12.86640026993276
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: Predicting clinical outcomes to anti-cancer drugs on a personalized basis is challenging in cancer treatment due to the heterogeneity of tumors. Traditional computational efforts have been made to model the effect of drug response on individual samples depicted by their molecular profile, yet overfitting occurs because of the high dimension for omics data, hindering models from clinical application. Recent research shows that deep learning is a promising approach to build drug response models by learning alignment patterns between drugs and samples. However, existing studies employed the simple feature fusion strategy and only considered the drug features as a whole representation while ignoring the substructure information that may play a vital role when aligning drugs and genes. Hereby in this paper, we propose TCR (Transformer based network for Cancer drug Response) to predict anti-cancer drug response. By utilizing an attention mechanism, TCR is able to learn the interactions between drug atom/sub-structure and molecular signatures efficiently in our study. Furthermore, a dual loss function and cross sampling strategy were designed to improve the prediction power of TCR. We show that TCR outperformed all other methods under various data splitting strategies on all evaluation matrices (some with significant improvement). Extensive experiments demonstrate that TCR shows significantly improved generalization ability on independent in-vitro experiments and in-vivo real patient data. Our study highlights the prediction power of TCR and its potential value for cancer drug repurpose and precision oncology treatment.

Related papers

• Estimating the Causal Effects of T Cell Receptors [20.01390828400336]
  We introduce a method to infer the causal effects of T cell receptor sequences on patient outcomes. Our approach corrects for unobserved confounders, such as a patient's environment and life history. As a demonstration, we use it to analyze the effects of TCRs on COVID-19 severity.
  arXiv  Detail & Related papers  (2024-10-18T02:45:14Z)
• Regressor-free Molecule Generation to Support Drug Response Prediction [83.25894107956735]
  Conditional generation based on the target IC50 score can obtain a more effective sampling space. Regressor-free guidance combines a diffusion model's score estimation with a regression controller model's gradient based on number labels.
  arXiv  Detail & Related papers  (2024-05-23T13:22:17Z)
• WISER: Weak supervISion and supErvised Representation learning to improve drug response prediction in cancer [7.9505208530650995]
  Cancer is a leading cause of death globally due to genomic changes and manifests heterogeneously across patients. variations in the distribution of genomic data and drug responses between cell lines and humans arise due to biological and environmental differences. Recent cancer drug response prediction methods have largely followed the paradigm of unsupervised domain-invariant representation learning. This paper addresses these challenges through a novel representation learning method in the first phase and weak supervision in the second.
  arXiv  Detail & Related papers  (2024-05-07T07:21:20Z)
• TransCDR: a deep learning model for enhancing the generalizability of cancer drug response prediction through transfer learning and multimodal data fusion for drug representation [4.740134482580255]
  We introduce TransCDR, which uses transfer learning to learn drug representations and fuses multi-modality features of drugs and cell lines by a self-attention mechanism. We are the first to systematically evaluate the generalization of the CDR prediction model to novel (i.e., never-before-seen) compound scaffolds and cell line clusters. TransCDR shows better generalizability than 8 state-of-the-art models.
  arXiv  Detail & Related papers  (2023-11-17T14:55:12Z)
• Enhancing drug and cell line representations via contrastive learning for improved anti-cancer drug prioritization [0.7070726553564699]
  We propose the use of contrastive learning to improve learned drug and cell line representations. We find that our learned representations exhibit a more balances reliance on drug- and cell line-derived features when making predictions.
  arXiv  Detail & Related papers  (2023-10-20T04:18:47Z)
• T Cell Receptor Protein Sequences and Sparse Coding: A Novel Approach to Cancer Classification [4.824821328103934]
  T cell receptors (TCRs) are essential proteins for the adaptive immune system. Recent advancements in sequencing technologies have enabled the comprehensive profiling of TCR repertoires. This has led to the discovery of TCRs with potent anti-cancer activity and the development of TCR-based immunotherapies.
  arXiv  Detail & Related papers  (2023-04-25T20:43:41Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• Orientation-Shared Convolution Representation for CT Metal Artifact Learning [63.67718355820655]
  During X-ray computed tomography (CT) scanning, metallic implants carrying with patients often lead to adverse artifacts. Existing deep-learning-based methods have gained promising reconstruction performance. We propose an orientation-shared convolution representation strategy to adapt the physical prior structures of artifacts.
  arXiv  Detail & Related papers  (2022-12-26T13:56:12Z)
• Lung Cancer Lesion Detection in Histopathology Images Using Graph-Based Sparse PCA Network [93.22587316229954]
  We propose a graph-based sparse principal component analysis (GS-PCA) network, for automated detection of cancerous lesions on histological lung slides stained by hematoxylin and eosin (H&E) We evaluate the performance of the proposed algorithm on H&E slides obtained from an SVM K-rasG12D lung cancer mouse model using precision/recall rates, F-score, Tanimoto coefficient, and area under the curve (AUC) of the receiver operator characteristic (ROC)
  arXiv  Detail & Related papers  (2021-10-27T19:28:36Z)
• Deep Learning for Virtual Screening: Five Reasons to Use ROC Cost Functions [80.12620331438052]
  deep learning has become an important tool for rapid screening of billions of molecules in silico for potential hits containing desired chemical features. Despite its importance, substantial challenges persist in training these models, such as severe class imbalance, high decision thresholds, and lack of ground truth labels in some datasets. We argue in favor of directly optimizing the receiver operating characteristic (ROC) in such cases, due to its robustness to class imbalance.
  arXiv  Detail & Related papers  (2020-06-25T08:46:37Z)
• A Systematic Approach to Featurization for Cancer Drug Sensitivity Predictions with Deep Learning [49.86828302591469]
  We train >35,000 neural network models, sweeping over common featurization techniques. We found the RNA-seq to be highly redundant and informative even with subsets larger than 128 features.
  arXiv  Detail & Related papers  (2020-04-30T20:42:17Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.